Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.63 EUR | +4.31% | +8.04% | +3.12% |
25/04 | UV Germi SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
12/04 | Global markets live: BP, Apple, Vodafone, Ford, Lockheed Martin... |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 9.731 | 10.5 | 19.91 | 19.38 | 10.26 | 11.22 |
Enterprise Value (EV) 1 | 6.263 | 8.125 | 18.06 | 18.85 | 6.674 | 11.22 |
P/E ratio | -26.8 x | 110 x | 48.5 x | -22.3 x | 155 x | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.82 x | 1.64 x | 2.9 x | 2.98 x | 1.4 x | 1.32 x |
EV / Revenue | 1.17 x | 1.27 x | 2.63 x | 2.9 x | 0.91 x | 1.32 x |
EV / EBITDA | -24.5 x | 70.7 x | 47.7 x | 137 x | 20.2 x | 17.8 x |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | 1.58 x | 1.69 x | 3 x | 3.28 x | 1.16 x | - |
Nbr of stocks (in thousands) | 2,561 | 2,549 | 2,570 | 2,563 | 3,109 | 3,187 |
Reference price 2 | 3.800 | 4.120 | 7.750 | 7.560 | 3.300 | 3.520 |
Announcement Date | 28/05/19 | 29/05/20 | 05/05/21 | 26/04/22 | 28/04/23 | 25/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 5.341 | 6.417 | 6.862 | 6.5 | 7.33 | 8.483 |
EBITDA 1 | -0.2555 | 0.115 | 0.3785 | 0.1373 | 0.3304 | 0.6285 |
EBIT 1 | -0.4489 | -0.0946 | 0.109 | -0.1757 | 0.0169 | 0.1336 |
Operating Margin | -8.41% | -1.47% | 1.59% | -2.7% | 0.23% | 1.58% |
Earnings before Tax (EBT) 1 | -0.5539 | -0.0901 | 0.1986 | -1.035 | -0.1068 | 0.1275 |
Net income 1 | -0.3612 | 0.0956 | 0.4103 | -0.8695 | 0.066 | 0.2901 |
Net margin | -6.76% | 1.49% | 5.98% | -13.38% | 0.9% | 3.42% |
EPS 2 | -0.1415 | 0.0374 | 0.1597 | -0.3393 | 0.0212 | - |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 28/05/19 | 29/05/20 | 05/05/21 | 26/04/22 | 28/04/23 | 25/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 3.47 | 2.38 | 1.86 | 0.52 | 3.58 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | -5.72% | 1.55% | 6.38% | -13.9% | 0.9% | - |
ROA (Net income/ Total Assets) | -3.46% | -0.72% | 0.76% | -1.27% | 0.11% | - |
Assets 1 | 10.44 | -13.31 | 53.9 | 68.46 | 58.15 | - |
Book Value Per Share 2 | 2.400 | 2.430 | 2.580 | 2.300 | 2.840 | - |
Cash Flow per Share 2 | 1.710 | 1.340 | 1.270 | 0.4200 | 1.420 | - |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 28/05/19 | 29/05/20 | 05/05/21 | 26/04/22 | 28/04/23 | 25/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.12% | 12.35M | |
+10.59% | 8.7B | |
+29.45% | 2.21B | |
-1.29% | 1.18B | |
+24.85% | 883M | |
-1.19% | 808M | |
-14.90% | 600M | |
+3.40% | 594M | |
-2.33% | 565M | |
-8.50% | 553M |
- Stock Market
- Equities
- ALUVI Stock
- Financials UV Germi